Immuno Cure
www.immunocure.hkWe are focusing on research and development of immunotherapies for cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA vaccine and Anti-Δ42PD1 Antibody Immuno Blocking technology platforms; with 2 vaccines in first-in-human clinical trials.
Read more
We are focusing on research and development of immunotherapies for cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA vaccine and Anti-Δ42PD1 Antibody Immuno Blocking technology platforms; with 2 vaccines in first-in-human clinical trials.
Read more
Country
City (Headquarters)
Hong Kong
Industry
Employees
11-50
Social
Employees statistics
View all employeesPotential Decision Makers
Commercial Manager "Corporate Finance Department"
Email ****** @****.comPhone (***) ****-****
Reach decision makers at Immuno Cure
Free credits every month!
Immuno Cure FAQ
Hong Kong, Hong Kong
Biotechnology Research
We'll help you understand if Lusha can solve your business needs.
